RIO DE JANEIRO, BRAZIL - A Brazilian company has begun test production of the active ingredient for Russia’s Sputnik V coronavirus vaccine and plans to reach full manufacturing in April, which would make it the first shot for which Brazil would not be dependent on imports.
“This week we started making a pilot lot of the active ingredient for learning purposes, not for use,” Miguel Giudicissi, chief science officer at União Química told Reuters.
Full local production of the Russian vaccine could be a lifeline for Brazil, which is struggling to get export permits for vaccine supplies stuck . . .